An upregulated expression of SPATS2L, a cytoplasmic RNA-binding protein linked to tumorigenicity in several cancers, has been associated with poor prognosis in esophageal squamous cell carcinoma and liver cancer [46]. This evidence concerns the gene SPATS2L and liver cancer.